213 related articles for article (PubMed ID: 33667959)
1. In vitro biomimetic models for glioblastoma-a promising tool for drug response studies.
Stanković T; Ranđelović T; Dragoj M; Stojković Burić S; Fernández L; Ochoa I; Pérez-García VM; Pešić M
Drug Resist Updat; 2021 Mar; 55():100753. PubMed ID: 33667959
[TBL] [Abstract][Full Text] [Related]
2. A novel 3D in vitro model of glioblastoma reveals resistance to temozolomide which was potentiated by hypoxia.
Musah-Eroje A; Watson S
J Neurooncol; 2019 Apr; 142(2):231-240. PubMed ID: 30694423
[TBL] [Abstract][Full Text] [Related]
3. Glioblastoma Chemoresistance: The Double Play by Microenvironment and Blood-Brain Barrier.
Da Ros M; De Gregorio V; Iorio AL; Giunti L; Guidi M; de Martino M; Genitori L; Sardi I
Int J Mol Sci; 2018 Sep; 19(10):. PubMed ID: 30248992
[TBL] [Abstract][Full Text] [Related]
4. Chemoresistance caused by the microenvironment of glioblastoma and the corresponding solutions.
Zhang X; Ding K; Wang J; Li X; Zhao P
Biomed Pharmacother; 2019 Jan; 109():39-46. PubMed ID: 30391707
[TBL] [Abstract][Full Text] [Related]
5. Pre-Clinical Drug Testing in 2D and 3D Human In Vitro Models of Glioblastoma Incorporating Non-Neoplastic Astrocytes: Tunneling Nano Tubules and Mitochondrial Transfer Modulates Cell Behavior and Therapeutic Respons.
Civita P; M Leite D; Pilkington GJ
Int J Mol Sci; 2019 Nov; 20(23):. PubMed ID: 31795330
[TBL] [Abstract][Full Text] [Related]
6. Transcriptomic Profiling of 3D Glioblastoma Tumoroids for the Identification of Mechanisms Involved in Anticancer Drug Resistance.
Chaicharoenaudomrung N; Kunhorm P; Promjantuek W; Rujanapun N; Heebkaew N; Soraksa N; Noisa P
In Vivo; 2020; 34(1):199-211. PubMed ID: 31882480
[TBL] [Abstract][Full Text] [Related]
7. Biomimetic brain tumor niche regulates glioblastoma cells towards a cancer stem cell phenotype.
Liu YC; Lee IC; Chen PY
J Neurooncol; 2018 May; 137(3):511-522. PubMed ID: 29357090
[TBL] [Abstract][Full Text] [Related]
8. A human co-culture cell model incorporating microglia supports glioblastoma growth and migration, and confers resistance to cytotoxics.
Leite DM; Zvar Baskovic B; Civita P; Neto C; Gumbleton M; Pilkington GJ
FASEB J; 2020 Jan; 34(1):1710-1727. PubMed ID: 31914660
[TBL] [Abstract][Full Text] [Related]
9. 3D modeling in cancer studies.
Atat OE; Farzaneh Z; Pourhamzeh M; Taki F; Abi-Habib R; Vosough M; El-Sibai M
Hum Cell; 2022 Jan; 35(1):23-36. PubMed ID: 34761350
[TBL] [Abstract][Full Text] [Related]
10. Brain-Mimetic 3D Culture Platforms Allow Investigation of Cooperative Effects of Extracellular Matrix Features on Therapeutic Resistance in Glioblastoma.
Xiao W; Zhang R; Sohrabi A; Ehsanipour A; Sun S; Liang J; Walthers CM; Ta L; Nathanson DA; Seidlits SK
Cancer Res; 2018 Mar; 78(5):1358-1370. PubMed ID: 29282221
[TBL] [Abstract][Full Text] [Related]
11. A Drug Screening Pipeline Using 2D and 3D Patient-Derived In Vitro Models for Pre-Clinical Analysis of Therapy Response in Glioblastoma.
Lenin S; Ponthier E; Scheer KG; Yeo ECF; Tea MN; Ebert LM; Oksdath Mansilla M; Poonnoose S; Baumgartner U; Day BW; Ormsby RJ; Pitson SM; Gomez GA
Int J Mol Sci; 2021 Apr; 22(9):. PubMed ID: 33919246
[TBL] [Abstract][Full Text] [Related]
12. Molecular Mechanisms of Treatment Resistance in Glioblastoma.
Ou A; Yung WKA; Majd N
Int J Mol Sci; 2020 Dec; 22(1):. PubMed ID: 33396284
[TBL] [Abstract][Full Text] [Related]
13. Validating antimetastatic effects of natural products in an engineered microfluidic platform mimicking tumor microenvironment.
Niu Y; Bai J; Kamm RD; Wang Y; Wang C
Mol Pharm; 2014 Jul; 11(7):2022-9. PubMed ID: 24533867
[TBL] [Abstract][Full Text] [Related]
14. Rapid identification and validation of novel targeted approaches for Glioblastoma: A combined ex vivo-in vivo pharmaco-omic model.
Daher A; de Groot J
Exp Neurol; 2018 Jan; 299(Pt B):281-288. PubMed ID: 28923369
[TBL] [Abstract][Full Text] [Related]
15. Investigation of chemoresistance-related genes mRNA expression for selecting anticancer agents in successful adjuvant chemotherapy for a case of recurrent glioblastoma.
Nagane M; Shibui S; Oyama H; Asai A; Kuchino Y; Nomura K
Surg Neurol; 1995 Nov; 44(5):462-8; discussion 468-70. PubMed ID: 8629231
[TBL] [Abstract][Full Text] [Related]
16. Toward 3D biomimetic models to understand the behavior of glioblastoma multiforme cells.
Rao SS; Lannutti JJ; Viapiano MS; Sarkar A; Winter JO
Tissue Eng Part B Rev; 2014 Aug; 20(4):314-27. PubMed ID: 24044776
[TBL] [Abstract][Full Text] [Related]
17. Intertumoral heterogeneity in patient-specific drug sensitivities in treatment-naïve glioblastoma.
Skaga E; Kulesskiy E; Fayzullin A; Sandberg CJ; Potdar S; Kyttälä A; Langmoen IA; Laakso A; Gaál-Paavola E; Perola M; Wennerberg K; Vik-Mo EO
BMC Cancer; 2019 Jun; 19(1):628. PubMed ID: 31238897
[TBL] [Abstract][Full Text] [Related]
18. Chemoresistance in high-grade gliomas: relevance of adenosine signalling in stem-like cells of glioblastoma multiforme.
Garrido W; Rocha JD; Jaramillo C; Fernandez K; Oyarzun C; San Martin R; Quezada C
Curr Drug Targets; 2014; 15(10):931-42. PubMed ID: 25174341
[TBL] [Abstract][Full Text] [Related]
19. Biomimetic models to examine microenvironmental regulation of glioblastoma stem cells.
Nakod PS; Kim Y; Rao SS
Cancer Lett; 2018 Aug; 429():41-53. PubMed ID: 29746930
[TBL] [Abstract][Full Text] [Related]
20. Chemoresistance of Cancer Cells: Requirements of Tumor Microenvironment-mimicking
Jo Y; Choi N; Kim K; Koo HJ; Choi J; Kim HN
Theranostics; 2018; 8(19):5259-5275. PubMed ID: 30555545
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
